Sands Capital announces $560 million life sciences fund
Sands Capital, based in Arlington, VA, has raised a whopping $560 million for its second life sciences fund.
As described in this recent DC Inno article, Sands Capital Life Sciences Pulse Fund II LP follows an earlier fund from 2018 focused on life sciences. Together the Pulse Strategy funds have $950 million in assets under management, Sands said.
Pulse II fund will make investments in private therapeutics, diagnostics and life sciences tools, with a mission to “help transform how diseases are defined, diagnosed and treated,” the firm announced.
